1. GLOBAL FINANCING FACILITY
IN SUPPORT OF
EVERY WOMAN EVERY CHILD

2. 2
Why Renewed Focus on RMNACH?
The efforts of countries and support from donors resulted in dramatic drop in child
and maternal morality rates from 1990 to 2013
• Under-5 mortality rate from 90 deaths per 1,000 live births to 46
• Maternal mortality rate from 380 deaths per 100,000 live births to 210
However more needs to be done
• Annually 6.6 million children still die and many of them due to preventable conditions
like malnutrition, pneumonia and malaria
• 11% of all births are to girls aged 15-19 years; complications linked to pregnancy and
childbirth second most common cause of death 2
Why: Global omentum to accelerate progress in RMNCAH…
0
10
20
30
40
50
60
70
80
90
100
1990 1995 2000 2005 2010 2015
Under-five mortality rate
(per 1,000 live births)
0
50
100
150
200
250
300
350
400
450
1990 1995 2000 2005 2010 2015
Maternal mortality ratio
(deaths per 100,000 live births)

3. 3
Significant additional investments are required to close the funding gap
• Over the past decade, the 75 highest burden countries spent nearly US$60 billion of
domestic government resources on RMNCAH which is complemented by donor
disbursements of an estimated US$9-9.5 billion.
• Despite these increases, a significant financing gap still remains
• Urgent need for a “grand convergence “ to accelerate the Investments in Women’s
and Children’s Health and the Lancet Commission on Investing in Health
• US$28-30 billion of additional financing (US$ 5.24 per person) is needed, in
large part due to up-front health systems strengthening investments
(particularly in low-income countries)
• By 2030, the total additional financing gap is projected to fall considerably to
about US$8 billion, or US$1.23 per person, due to a combination of increased
domestic financing and reduced health systems strengthening costs
• Civil registration and vital statistics (CRVS) system is a critical platform for promoting
women and children’s health.
• over 100 developing countries lack well-functioning CRVS systems.
• almost 230 million children under the age of five are not registered.
• progress with death registration has been slow globally

4. 4
Why GFF?
Build on the unprecedented level of global support for the SDGs and the
Strategy for Every Woman and Every Child provide an opportunity to step
up efforts and achieve the ambitious but realizable goal of “convergence” by
2030.
Facilitate the grand coalition to bring together the domestic and external
financing for RMNCAH
• Family Planning 2020,
• the H4+ Partnership,
• the Health Results Innovation Trust Fund,
• the Thematic Trust Fund for Maternal Health,
• the Global Program to Enhance Reproductive Health Commodity Security,
• The Bridge Fund,
• the Pledge Guarantee for Health and the RMNCH Trust Fund.
Realize the benefits of accelerated investment that would help to prevent a
total of 4 million maternal deaths, 107 million child deaths, and 22 million
stillbirths between 2015 and 2030 in the Countdown countries

5. 5
Outline of the GFF
Smart
Scaled
Sustainable
Results
1. County Investment
Cases for RMNCAH
2. Health financing
strategies
The “what” of the GFF The “how” of the GFF The “who” of the GFF
The GFF
Partnership
The GFF
Trust
Fund

6. 6
What: Smart “best buy” interventions cut across sectors
Clinical service delivery and
preventive interventions
Health systems
strengthening
Multisector
approaches
End preventable maternal and child deaths and improve the health and quality of
life of women, children, and adolescentsServicedelivery
approaches
CRVS
Equity, gender, and rights
Mainstreamed across areas
• Country led process
• Strong evidence base (Best buys relevant for the country context)
• Equity:
• Underinvested areas (e.g., family planning, nutrition) and groups (e.g., adolescents)
• Underserved populations
• Innovations to improve service delivery (e.g., integration, task-shifting, community
health workers, private sector)

7. 7
The RMNCAH Investment Case
Core analytics
Consultation
Agreement
on 2030
results
(impact-
level) and
main
obstacles to
be focused
on
Agreement
interventions
(long- and
short-term) to
address
obstacles and
expected
results; and
costs &
benefits
Analysis of
obstacles for
• demand
• supply
• enabling
environment
• Multi-
sectoral
factors
High-level vision of the Country Detailed diagnosis and prioritization
Investment
Case

8. 8
Complementary financing of the Investment Case
InvestmentCase
Government
Donor
1
GFF Trust
Fund +
IDA/IBRD
GAVI or
GFATM
Donor
2
Donor
1
Donor
3
Private
sector
Government
Improving alignment to reduce gaps and overlaps as financiers increase funding for
RMNCAH and technical support e.g. from H4+ partners

9. 9
The investment case and financing strategy in tandem
RMNCAH investment case
• Timeframe: 3-5 years implementation, nested in a longer term vision for 2030
• Includes RMNCAH needs assessment, identification of prioritized smart
interventions (clinical, health systems, multi-sectoral)
• County relevant innovations for scaling-up : delivery strategies to get better value
for domestic and harmonized donor resources
Financing strategy
• Health sector-wide
• Timeframe: through 2030
• Identifies approach for sustainable financing (public and private) for achieving UHC
• Includes financing assessment, Domestic resource mobilization and pooling,
Strategic purchasing and efficient payment supported by relevant policy changes,
public finance and administration reforms

10. GFF is informed by four frontrunner countries
• Front runner countries:
• DRC, Ethiopia, Kenya and Tanzania
• Second round countries:
Bangladesh, Cameron, India, Liberia, Mozambique, Nigeria,
Senegal, Uganda
• Other countries will be identified in future
10